Compare ADVB & IROQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ADVB | IROQ |
|---|---|---|
| Founded | 2014 | 1883 |
| Country | United States | United States |
| Employees | 31 | N/A |
| Industry | Medical Specialities | Savings Institutions |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 109.2M | 91.6M |
| IPO Year | N/A | 2011 |
| Metric | ADVB | IROQ |
|---|---|---|
| Price | $3.72 | $27.81 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 90.0K | 8.8K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | ★ 1.45% |
| EPS Growth | N/A | ★ 140.35 |
| EPS | N/A | ★ 0.84 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $1.26 | $32.98 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.19 | $23.01 |
| 52 Week High | $4.64 | $29.00 |
| Indicator | ADVB | IROQ |
|---|---|---|
| Relative Strength Index (RSI) | 96.59 | 56.49 |
| Support Level | $0.38 | $27.09 |
| Resistance Level | N/A | $27.93 |
| Average True Range (ATR) | 0.14 | 0.45 |
| MACD | 0.47 | -0.03 |
| Stochastic Oscillator | 93.49 | 26.97 |
Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
IF Bancorp Inc is a holding company mainly engaged in the business of directing, planning, and coordinating the business activities of Iroquois Federal. The company, in association, takes deposits from the general public and invests those deposits together with funds generated from operations and borrowings in various loans such as multi-family residential and mortgage loans, commercial real estate loans, home equity lines of credit, consumer loans, etc., and offers a variety of deposit accounts and alternative delivery channels. In addition to the traditional banking products and services, the group also offers a full line of property and casualty insurance products, annuities, mutual funds, individual securities, managed accounts, and other financial services.